SNAP-8

SNAP-8 (Topical)

SNAP‑8 (Acetyl Octapeptide‑3) is a cosmetic peptide used topically and studied as a ‘botox‑like’ peptide that may reduce the appearance of expression lines by modulating SNARE-complex mediated neurotransmitter release at the neuromuscular junction in skin.

Dosing Protocols

Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
Typical daily range: 330–1,000 mcg once daily (gradual titration over 8–12 weeks).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C; reconstituted: refrigerate at 2–8 °C, avoid freeze-thaw cycles.

Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Cycle Length: 8–12 weeks; optional extension to 16 weeks.
Goal: Support reduction of expression lines and wrinkles through gentle muscle relaxation.

Frequency: Inject once daily subcutaneously.

Phase	Dose	Syringe (U-100)
Weeks 1–4	330 mcg (0.33 mg)	10 units (0.10 mL)
Weeks 5–8	500 mcg (0.50 mg)	15 units (0.15 mL)
Weeks 9–12	1,000 mcg (1.0 mg)	30 units (0.30 mL)

Benefits

• May reduce the appearance of dynamic expression lines (crow’s feet, forehead) with consistent topical use
• Potential smoothing effect on skin texture
• May complement other anti-aging actives (retinoids, peptides, SPF)
• Generally well tolerated in cosmetic formulations
• Non-invasive alternative to neuromodulator injections (cosmetic effect, not equivalent)

Mechanism of Action

SNAP‑8 is derived from the SNAP‑25 protein sequence and is proposed to interfere with the SNARE complex involved in acetylcholine vesicle fusion and release. Reduced acetylcholine signaling at superficial facial muscles may decrease microcontractions, softening the appearance of expression wrinkles over time.

Side Effects

• Skin irritation (redness, burning)
• Dryness/flaking
• Contact dermatitis
• Eye irritation if applied too close to eyes

Side Effect Management

• Patch test 24–48h prior to regular use
• Apply to intact skin; avoid broken/irritated areas
• Use a bland moisturizer and reduce frequency if irritation occurs
• Avoid direct application on eyelids or mucosal surfaces

Contraindications

• Known allergy to peptide/cosmetic ingredients
• Active dermatitis/eczema flare at application site
• Use with caution during pregnancy/breastfeeding (limited data for cosmetic peptides)

Research Citations

PubMed/DOI-linked citations for verification. Many studies are preclinical (animal/in-vitro) or early clinical.

1. Blanes-Mira C et al. A synthetic hexapeptide (Argireline) with botulinum toxin-like activity. (related SNARE-targeting cosmetic peptide concept). DOI Link
2. Pickart L, Margolina A. Bioactive peptides and their role in skin aging (review). DOI Link
3. Sudhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. (SNARE mechanism review). DOI Link

---